Onco'Zine

A detailed Overview for Clinicians

Definition and Epidemiology: Nasopharyngeal carcinoma (NPC) is a distinct, aggressive epithelial malignancy originating from the nasopharynx's mucosal lining, most commonly in the fossa of Rosenmüller*.

Although rare globally with less than 100,000 patients diagnosed each year, it has a high incidence in Southern China, Southeast Asia, the Arctic, and the Middle East/North Africa. NPC is classified histologically per the World Health Organization (WHO) as either keratinizing squamous cell carcinoma (Grade I) or nonkeratinizing carcinoma (Grades II & III), the latter strongly associated with Epstein-Barr virus (EBV) infection. Emerging data suggest a subset of nonendemic NPCs may be linked to human papillomavirus (HPV).[1][2][3]

Etiology and Risk Factors: EBV infection is the principal etiological factor for endemic NPC, while dietary factors (notably high intake of salt-cured fish/meats), Asian or North African ancestry, family history, and possible HPV infection in nonendemic regions contribute additional risk.

Clinical Presentation: Symptoms are often insidious, with most patients (>70%) presenting with locoregionally advanced or metastatic disease at diagnosis due to the tumor's deep location and aggressive nature. Common features include:

• Painless cervical lymphadenopathy (present in ~75% of cases)
• Cranial nerve palsies (II–VI, IX–XII), resulting in headaches, diplopia, facial numbness
• Nasal obstruction or epistaxis
• Otologic symptoms (hearing loss, tinnitus, recurrent otitis media)

Diagnosis Workup includes:

• Detailed head and neck examination, including nasoendoscopy
• MRI or PET/CT for local and systemic staging
• Biopsy for histopathological confirmation and WHO grading
• Plasma EBV DNA quantification (in endemic regions) for diagnosis, prognostication, and treatment stratification
• Neurological assessment for cranial nerve involvement

Staging: The 9th edition of the TNM staging system (2025) introduces key updates: downgrading localized disease stage groups and subdividing metastatic NPC into IVA/IVB based on metastatic burden, influencing therapy and trial design.

Treatment Approaches:

• Early-stage (I): Radiation therapy alone can cure ~90% of patients
• Locoregionally advanced (II–IV): Multimodal therapy is standard, often with induction chemotherapy (IC) followed by concurrent chemoradiation. Recent trials have optimized sequencing and target delineation.
• Recurrent/metastatic (R/M): Platinum-doublet chemotherapy and anti–PD-1 immunotherapies are new standards. For those failing these, novel agents—including bispecific antibodies and antibody-drug conjugates—are under investigation.
• Surgery: Rarely used as primary treatment due to anatomical complexity

Prognosis and Biomarkers Plasma EBV DNA is an archetypal biomarker in endemic NPC, used for risk stratification and in ongoing precision therapy trials. Prognosis depends on stage at diagnosis, EBV DNA levels, and response to therapy.

Note: * The fossa of Rosenmüller (also known as the pharyngeal recess) is a deep, mucosal-lined pocket in the roof of the nasopharynx, located just behind the Eustachian tube opening. It is clinically significant as the most common site of origin for nasopharyngeal carcinomas and benign retention cysts.

Reference
[1] Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015 Jan;32(1):54-73. doi: 10.1053/j.semdp.2015.02.021. Epub 2015 Feb 25. PMID: 25769204.
[2] Jainar CJE, Jacomina LE, Dee EC, Lee A, Lee NY, Chua MLK, Mejia MBA. Global Disparities in Current Clinical Trials in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2025 Nov 15;123(4):1041-1049. doi: 10.1016/j.ijrobp.2025.06.3870. Epub 2025 Jul 3. PMID: 40614784.
[3] Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, Yang CS. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001 Dec 27;345(26):1877-82. doi: 10.1056/NEJMoa011610. PMID: 11756578.
[4] Huang H, Yao Y, Deng X, Huang Z, Chen Y, Wang Z, Hong H, Huang H, Lin T. Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). Int J Oncol. 2023 Aug;63(2):97. doi: 10.3892/ijo.2023.5545. Epub 2023 Jul 7. PMID: 37417358; PMCID: PMC10367053.

__

Copyright © 2026 American Association for Medical Education and Information (AAMEI).

A Guide for Patients

What is NPC? Nasopharyngeal carcinoma (NPC) is a rare cancer that starts in the upper part of your throat, behind your nose (the nasopharynx). Because of where it grows, it can affect your hearing, breathing, or speaking.

Causes & Risk Factors NPC is most strongly linked to infection with the Epstein-Barr virus (EBV), but your risk also increases if you are of Asian or North African descent, have a family history of NPC, or eat a diet high in salt-cured fish and meats. For some, the human papillomavirus (HPV) may also play a role.

Signs & Symptoms NPC does not necessarily cause clear often symptoms until the tumor is larger. Common signs & symptoms may include:

• A painless lump in your neck or behind your nose
• Stuffy (or blocked) nose, nosebleeds, or bloody mucus
• Ear infections, ringing in the ears (tinnitus), or hearing loss
• Headaches or sore throat

Diagnosis: If NPC is suspected, your doctors will look into your nose and throat, order imaging scans (like MRI or CT), and take a small sample (biopsy) to check for cancer. In addition, special blood tests for EBV DNA may be used to diagnosis and monitoring the disease.

Treatment: NPC is very treatable, especially when caught early. Main treatments include:

• Radiation therapy: This approach is the most common therapy and often very effective
• Chemotherapy: This treatment approach is often combined with radiation for more advanced cases
• Immunotherapy: This treatment may include novel therapies designed to help your immune system fight cancer, and may benefit you especially if the cancer comes back or spreads

Surgery is rarely needed because of the tumor’s location. Your treatment will be tailored to your situation.

Summary: NPC is rare but often treatable. Early diagnosis and treatment give the best chance for a cure. If you have symptoms or are at risk, see your doctor right away..

__

Disclaimer: The information provided on this website is for educational and general informational purposes only. It is not intended to be, nor does it serve as, a substitute for professional medical advice, diagnosis, treatment. If you have questions regarding a health condition, always seek the advice of a qualified healthcare professional. Never delay seeking or disregard professional medical advice because of something you have read here.